These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18363767)

  • 1. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
    Mizukawa Y; Yamazaki Y; Shiohara T
    Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization.
    Teraki Y; Shiohara T
    Dermatology; 2004; 209(1):29-32. PubMed ID: 15237264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed drug eruption: pathogenesis and diagnostic tests.
    Shiohara T
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):316-21. PubMed ID: 19474709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of IL-10-producing CD4+ and CD8+ T cells in fixed drug eruption.
    Teraki Y; Kokaji T; Shiohara T
    Dermatology; 2006; 213(2):83-7. PubMed ID: 16902283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
    Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells.
    Shiohara T; Mizukawa Y
    Eur J Dermatol; 2007; 17(3):201-8. PubMed ID: 17478380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption.
    Teraki Y; Shiohara T
    J Allergy Clin Immunol; 2003 Sep; 112(3):609-15. PubMed ID: 13679823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunological basis of lichenoid tissue reaction.
    Shiohara T; Mizukawa Y
    Autoimmun Rev; 2005 Apr; 4(4):236-41. PubMed ID: 15893718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed drug eruption: the dark side of activation of intraepidermal CD8+ T cells uniquely specialized to mediate protective immunity.
    Shiohara T; Mizukawa Y
    Chem Immunol Allergy; 2012; 97():106-21. PubMed ID: 22613857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
    Friedmann PS; Strickland I; Pirmohamed M; Park BK
    Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses.
    Mizukawa Y; Shiohara T
    Clin Exp Dermatol; 2010 Jul; 35(5):493-7. PubMed ID: 19874369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.
    Mizukawa Y; Shiohara T
    Curr Allergy Asthma Rep; 2009 Jan; 9(1):71-7. PubMed ID: 19063828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions.
    Schlapbach C; Zawodniak A; Irla N; Adam J; Hunger RE; Yerly D; Pichler WJ; Yawalkar N
    Allergy; 2011 Nov; 66(11):1469-76. PubMed ID: 21819408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly.
    Provinciali M; Moresi R; Donnini A; Lisa RM
    Gerontology; 2009; 55(3):314-21. PubMed ID: 19190395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.
    Miyauchi H; Hosokawa H; Akaeda T; Iba H; Asada Y
    Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
    Merot Y; Gravallese E; Guillén FJ; Murphy GF
    Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris.
    Teraki Y; Miyake A; Takebayashi R; Shiohara T
    Clin Exp Dermatol; 2004 Nov; 29(6):658-63. PubMed ID: 15550147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.